Advertisement
BFLY vs PACB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFLY is a Hold and PACB is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BFLY’s FA Score shows that 0 FA rating(s) are green whilePACB’s FA Score has 0 green FA rating(s).
- BFLY’s FA Score: 0 green, 5 red.
- PACB’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BFLY’s TA Score shows that 3 TA indicator(s) are bullish while PACB’s TA Score has 5 bullish TA indicator(s).
- BFLY’s TA Score: 3 bullish, 4 bearish.
- PACB’s TA Score: 5 bullish, 4 bearish.
Price Growth
BFLY (@Medical/Nursing Services) experienced а -12.69% price change this week, while PACB (@Medical/Nursing Services) price change was -3.57% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.20%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -5.15%.
Reported Earning Dates
BFLY is expected to report earnings on Oct 29, 2026.
PACB is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-4.20% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BFLY | PACB | BFLY / PACB | |
| Capitalization | 1.96B | 420M | 467% |
| EBITDA | -66.32M | -103.11M | 64% |
| Gain YTD | 93.684 | -27.807 | -337% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 112M | 160M | 70% |
| Total Cash | 125M | 276M | 45% |
| Total Debt | 19.1M | 703M | 3% |
BFLY | PACB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 74 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 62 | |
P/E GROWTH RATING 1..100 | 100 | 70 | |
SEASONALITY SCORE 1..100 | 11 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BFLY's Valuation (43) in the null industry is somewhat better than the same rating for PACB (99) in the Biotechnology industry. This means that BFLY’s stock grew somewhat faster than PACB’s over the last 12 months.
BFLY's Profit vs Risk Rating (100) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that BFLY’s stock grew similarly to PACB’s over the last 12 months.
BFLY's SMR Rating (98) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that BFLY’s stock grew similarly to PACB’s over the last 12 months.
BFLY's Price Growth Rating (34) in the null industry is in the same range as PACB (62) in the Biotechnology industry. This means that BFLY’s stock grew similarly to PACB’s over the last 12 months.
PACB's P/E Growth Rating (70) in the Biotechnology industry is in the same range as BFLY (100) in the null industry. This means that PACB’s stock grew similarly to BFLY’s over the last 12 months.
| BFLY | PACB | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 80% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 89% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 82% |
| Advances ODDS (%) | N/A | 11 days ago 84% |
| Declines ODDS (%) | 3 days ago 89% | 5 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 87% |
Advertisement